COVID-19 infection therapeutic interfering particle therapy (intranasal) (J David Gladstone Institutes)

N/A

Report date: 2025/01/26 16:27:43
NME

Base Information

Drug NameCOVID-19 infection therapeutic interfering particle therapy (intranasal) (J David Gladstone Institutes)
Drug Alias NameTIPs
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJ David Gladstone Institutes
China Registration ClassN/A

Develop Information

Active CompaniesJ David Gladstone Institutes
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A